Congratulations to our chemists succeeded in developing the Baricitinib intermediate series !

Congratulations to our chemists succeeded in developing the  Baricitinib intermediate series !

now we can supply the below Baricitinib intermediate with stable production and high quality :

1)  Baricitinib API , cas:1187594-09-7;

2)  Baricitinib intermediate--4-(1-(1-ethoxyethyl)-1H-pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin;  cas:  1187595-88-5;

3) Baricitinib intermediate--1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole   

cas:1029716-44-6;

4)  Baricitinib intermediate--1-Boc-3-(cyanomethylene)azetidine     

cas:1153949-11-1;

5) Baricitinib intermediate--2-(1-(ethylsulfonyl)azetidin-3-ylidene)acetonitrile

cas:1187595-85-2;

6)   Baricitinib intermediate--4-(1H-PYRAZOL-4-YL)-7-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-7H-PYRROLO[2,3-D]PYRIMIDINE

cas:941685-27-4;

7)   Baricitinib intermediate--2-(azetidin-3-ylidene)acetonitrile (hydrochloride)

cas:1314910-43-4

< return >